ACC 2010 schedule: Difference between revisions

Jump to navigation Jump to search
Line 104: Line 104:


===4:30 PM===
===4:30 PM===
===5:00 PM===
*'''Interviewee:''' Henry Ginsberg
*'''Trial:''' Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study





Revision as of 17:28, 9 February 2010

Here is the page we will use to coordinate interviews at ACC 2010

Filming location: Atlanta Marriott Downtown 160 Spring Street Atlanta, GA 30303

Filming will occur from Saturday to Tuesday (March 13 - March 16). Dr. Gibson is available to interview during all times listed in black. For all times listed in green, Dr. Gibson is unavailable to conduct the interview. You may, however, go ahead and speak about your topic/present your slides.



Click on Date for Detailed Schedule

Saturday March 13, 2010

Sunday March 14, 2010

Monday March 15, 2010

Tuesday March 16, 2010


Saturday, March 13, 2010

8:30 AM

9:00 AM

  • Interviewee:
  • Trial:

9:30 AM

10:00 AM

  • Interviewee:
  • Trial:

10:30 AM

  • Interviewee:
  • Trial:

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:00 PM

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Sunday March 14, 2010

8:30 AM

9:00 AM

9:30 AM

10:00 AM

10:30 AM

11:00 AM

11:30 AM

12:00 PM

12:30 PM

1:00 PM

1:30 PM

  • Interviewee:
  • Trial:

2:00 PM

  • Interviewee: Francois Schiele
  • Trial: Effects of Clinical Characteristics and Treatments on Gender Difference in Outcomes after Acute Myocardial Infarction: A Propensity Score-Matched Analysis

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

5:00 PM

  • Interviewee: Henry Ginsberg
  • Trial: Effects of Combination Lipid Therapy on Cardiovascular Events in Type 2 Diabetes Mellitus: The ACCORD Lipid Study


Return to top

Monday March 15, 2010

8:30 AM

9:00 AM

  • Interviewee: Robert A. Byrne
  • Trial: Randomized Trial of a Polymer-Free Dual Drug-Eluting Stent versus Polymer-Based Cypher and Endeavor Drug-Eluting Stents - Two-year Clinical and Angiographic Outcomes

9:30 AM

  • Interviewee: Steven Goldman
  • Trial: A Randomized Trial Radial Artery Grafts versus Saphenous Vein Grafts in Coronary Artery Bypass Surgery: VA Cooperative Study

10:00 AM

  • Interviewee: Ted Feldman
  • Trial: Primary Safety and Efficacy Endpoints of the EVEREST II Randomized Clinical Trial

10:30 AM

  • Interviewee: Michael D. Ezekowitz
  • Trial: A Randomized Clinical Trial of Three Doses of a Long-Acting Oral Direct Factor Xa Inhibitor Betrixaban in Patients With Atrial Fibrillation

11:00 AM

  • Interviewee:
  • Trial:

11:30 AM

  • Interviewee:
  • Trial:

12:00 PM

12:30 PM

1:00 PM

1:30 PM

2:15 PM

  • Interviewee: Isabelle C. Van Gelder
  • Trial: Rate Control Efficacy in Permanent Atrial Fibrillation: a Comparison Between Lenient Versus Strict Rate Control in Patients With and Without Heart Failure. The RACE II Study

2:30 PM

3:00 PM

3:30 PM

4:00 PM

4:30 PM

Return to top

Tuesday March 16, 2010

8:30 AM

9:00 AM

9:30 AM

  • Interviewee: Robert E. Michler
  • Trial: Influence of Reduction of Left Ventricular Volume on Outcome After Coronary Artery Bypass Grafting With or Without Surgical Ventricular Reconstruction

10:00 AM

10:30 AM

11:00 AM

Return to top